查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439193

全球血糖监测系统市场评估：按类型、组件、产品、病患照护环境、应用、模式、入侵性别、通路、地区、机会、预测（2017-2031）

Glucose Monitoring System Market Assessment, By Type, By Component, By Product, By Patient Care Setting, By Application, By Modality, By Invasiveness, By Distribution Channel, By Region, By Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 226 Pages | 商品交期: 3-5个工作天内

价格

全球血糖监测系统市场规模预计将从 2023 年的 252.1 亿美元增至 2031 年的 554.3 亿美元，在 2024-2031 年预测期内复合年增长率为 10.35%。 市场的主要驱动因素是全球糖尿病患者数量的不断增加、技术的不断进步、患者对非侵入性监测的偏好、对定期血糖监测在糖尿病管理中的重要性的认识不断提高以及政府这些包括更多的措施和医疗改革、医疗成本上升、老年人口不断增长，以及远距医疗和数位健康平台与血糖监测的整合。

推动全球血糖监测市场的主要催化剂是糖尿病尤其是2型糖尿病盛行率的上升，这与不健康的饮食习惯和久坐的生活方式等生活方式因素密切相关。 随着世界糖尿病人口在可预见的未来预计将显着增长，对可靠、高效的血糖监测解决方案的需求正在迅速增加。 此外，技术进步使血糖监测发生了革命性的变化，创造了连续血糖监测 (CGM) 系统、智慧血糖仪和行动健康应用程式等创新设备。 这些突破提供了即时数据，提高了便利性和易用性，并有助于提高患者的依从性和整体改善医疗保健结果。

此外，计划中的联盟、合併和收购正在重塑竞争格局。 这些合作旨在扩大产品范围、加强全球市场渗透并加速研发活动。 最终，我们将增加糖尿病患者可用的监测和管理选项，并提供改进的解决方案，从而推动全球血糖监测市场。

全球糖尿病患者数量增加

全球糖尿病患者数量的增加正在导致全球血糖监测系统市场的成长。 目前，全球有超过 5 亿人患有糖尿病，影响所有性别和年龄层的人。 预计未来30年内这个数字将超过13亿，每个国家都呈现成长趋势。 目前，糖尿病的全球盛行率为6.1%，使其成为全球十大死亡和残疾原因之一。 从各个地区来看，北非和中东的盛行率最高，为 9.3%，预计到 2050 年将跃升至 16.8%。 同样，拉丁美洲和加勒比地区的比例预计将上升至 11.3%。 在所有国家中，糖尿病在65岁以上的人群中最为流行，该人群的患病率在全球范围内超过20%。 75岁至79岁年龄组盛行率最高，达24.4%。 从各地区的数据来看，北非和中东的比例最高，为39.4%。 另一方面，中欧、东欧和中亚的比率最低，为 19.8%。

科技进步推动市场

技术进步正在加强全球血糖监测系统市场。 因此，血糖监测设备的采用不断增加，从而加强了糖尿病管理。 多种可穿戴式血糖监测设备正在开发中，使糖尿病患者无需刺穿手指即可监测血糖水平。 新的解决方案正在被引入以简化流程，为医疗保健专业人员提供有价值的临床见解，并最终提高他们提供优质患者护理的能力。 例如，2024年2月6日，糖尿病患者连续血糖监测（CGM）领域的全球领导者DexCom宣布推出其最新的CGM设备Dexcom ONE+。 该系统很快将在荷兰推出，目前在西班牙、比利时和波兰可用。 Dexcom ONE+ 采用 Dexcom 最准确、一流的感光元件设计。

本报告研究和分析了全球血糖监测系统市场，提供市场规模和预测、市场动态以及主要参与者的现状和前景。

目录

第一章研究方法

第 2 章专案范围与定义

第 3 章 COVID-19 的影响

第 4 章执行摘要

第五章全球血糖监测系统市场展望（2017-2031）

  • 市场规模与预测
    • 金额
    • 数量
  • 依类型
    • 自我监测血糖 (SMBG) 系统
    • 连续血糖监测 (CGM) 系统
  • 按组件
    • 血糖机装置
    • 测试条
    • 柳叶刀
    • 感测器
    • 耐用消费品
  • 按产品
    • 设备
    • 服务
  • 依病患照护环境分类
    • 医院
    • 居家护理
  • 依用途
    • 1 型糖尿病
    • 2 型糖尿病
    • 妊娠糖尿病
  • 按方式
    • 穿戴式
    • 不可穿戴
  • 侵入性性行为
    • 侵入性技术
    • 微创技术
    • 非侵入性方法
  • 按分销管道
    • 零售店
    • 电子商务
    • 药房
  • 按地区
    • 北美
    • 欧洲
    • 南美洲
    • 亚太地区
    • 中东/非洲
  • 市占率：依公司划分（2023 年）

第 6 章全球血糖监测系统市场展望：按地区划分（2017-2031 年）

  • 北美
    • 市场规模与预测
    • 依类型
    • 按组件
    • 按产品
    • 依病患照护环境分类
    • 依用途
    • 按方式
    • 侵入性性行为
    • 按分销管道
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 英国
    • 俄罗斯
    • 荷兰
    • 西班牙
    • 土耳其
    • 波兰
  • 南美洲
    • 巴西
    • 阿根廷
  • 亚太地区
    • 印度
    • 中国
    • 日本
    • 澳大利亚
    • 越南
    • 韩国
    • 印尼
    • 菲律宾
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 南非

第 7 章市场地图（2023 年）

  • 依类型
  • 按组件
  • 按产品
  • 依病患照护环境分类
  • 依用途
  • 按方式
  • 侵入性性行为
  • 按分销管道
  • 按地区

第八章宏观环境与产业结构

  • 需求与供给分析
  • 进出口分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第 9 章市场动态

  • 生长促进因素
  • 抑製成长的因素（问题、限制因素）

第 10 章监理架构与创新

  • 临床试验
  • 专利情况
  • 监理机关的核准
  • 创新/新技术

第十一章主要公司状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析（2023 年）
  • 併购/合资企业（如果适用）
  • SWOT 分析（5 家公司进入市场）
  • 专利分析（如果适用）

第十二章价格分析

第 13 章案例研究

第14章主要公司展望

  • Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • LifeScan IP Holdings
  • Ascensia Diabetes Care Holdings AG.
  • Medtronic Plc.
  • Dexcom, Inc.
  • Ypsomed AG
  • B. Braun Medical Ltd.
  • Nipro Corporation
  • Sanofi S.A.

第 15 章策略建议

第16章关于我们公司，免责声明

Product Code: MX11029

Global glucose monitoring system market is projected to witness a CAGR of 10.35% during the forecast period 2024-2031, growing from USD 25.21 billion in 2023 to USD 55.43 billion in 2031. Several key factors that are driving the global glucose monitoring market include a global increase in diabetes cases, ongoing advancements in technology, patient preference for non-invasive monitoring, growing awareness about the importance of regular blood glucose monitoring in diabetes management, increased government initiatives and healthcare reforms, rising healthcare expenditure, growing aging population, and the integration of glucose monitoring with telemedicine and digital health platforms.

A primary catalyst propelling the global glucose monitoring market is the escalating incidence of diabetes, especially type 2 diabetes, closely associated with lifestyle factors such as unhealthy dietary habits and sedentary lifestyles. As the global diabetic population is projected to experience substantial growth in the foreseeable future, there is a burgeoning demand for dependable and efficient blood glucose monitoring solutions. Additionally, blood glucose monitoring has been revolutionized by technological advancements, giving rise to innovative devices such as continuous glucose monitoring (CGM) systems, intelligent glucose meters, and mobile health applications. These breakthroughs deliver real-time data and provide heightened convenience and user-friendliness, contributing to enhanced patient adherence and overall improvements in healthcare outcomes.

Moreover, deliberate alliances, consolidations, and corporate takeovers are reconfiguring the competitive environment. These cooperative ventures aim to broaden product ranges, augmenting worldwide market penetration and expediting research and development initiatives. In the end, they serve to advance the monitoring and management options available to individuals with diabetes, offering them improved solutions, hence driving the global glucose monitoring market.

Global Increase in Diabetes Cases

The global increase in the number of diabetes cases has led to the growth of the global glucose monitoring system market. Over 500 million individuals across the globe are currently grappling with diabetes, a condition that spans across gender and age groups in all nations. This number is expected to surpass 1.3 billion within the next three decades, with an upward trend witnessed in every country. Currently, diabetes boasts a global prevalence rate of 6.1%, firmly placing it among the top 10 leading causes of death and disability worldwide. Zooming in on super-regions, North Africa and the Middle East exhibit the highest rate at 9.3%, which is anticipated to surge to 16.8% by 2050. Similarly, the projected rate is set to rise to 11.3% in Latin America and the Caribbean. Diabetes was notably prominent among individuals aged 65 and above across all countries, registering a prevalence rate of over 20% for this demographic on a global scale. The highest rate was observed in the age bracket of 75 to 79, reaching 24.4%. Analyzing the data by super-regions, North Africa and the Middle Eas t had the highest rate within this age group, 39.4%. At the same time, Central Europe, Eastern Europe, and Central Asia displayed the lowest rate at 19.8%.

Technological Advancements are Driving the Market

Advancements in technology are enhancing the global glucose monitoring system market. Consequently, there is a growing adoption of blood glucose monitoring devices, resulting in enhanced diabetes management. Multiple wearable glucose monitoring devices are in the works, offering people with diabetes the ability to monitor their blood sugar levels without the need for finger pricking. Emerging solutions are being introduced to streamline processes and provide healthcare professionals with valuable clinical insights, ultimately enhancing their ability to deliver superior patient care. For example, on February 6, 2024, DexCom, Inc., a world leader in continuous glucose monitoring (CGM) for those with diabetes, announced the release of Dexcom ONE+, their newe st CGM device. The system will soon be introduced in the Netherlands and is currently accessible in Spain, Belgium, and Poland. The most accurate and best-in-class sensor design from Dexcom is used in Dexcom ONE+.

Government Initiatives

Notable rise in government initiatives focused on glucose monitoring devices has led to increased growth of global glucose monitoring system market. These initiatives reflect a coordinated endeavor by governments to confront the complexities associated with diabetes and improve the well-being of those affected by the condition. These efforts encompass a spectrum of policies, regulations, and programs aimed at advancing the accessibility, affordability, and efficacy of glucose monitoring devices, to improve diabetes management and healthcare results. For instance, in March 2022, the government of England unveiled a significant initiative where life-altering flash glucose monitors were provided to all individuals with type 1 diabe tes. These compact wearable devices, approximately the size of a £2 coin, feature a sensor conveniently placed on the arm, enabling patients to swiftly assess their glucose levels with a mere one-second scan. These monitors seamlessly connect to a user-friendly smartphone app, granting individuals access to the data collected by the device.

Growing Popularity of Continuous Glucose Monitoring (CGM) Systems

The worldwide incidence of diabetes is on the rise, resulting in a heightened growth in the global glucose monitoring market. Individuals with diabetes are becoming increasingly conscious of the significance of regular blood glucose level monitoring to prevent conditions like hypoglycemia and hyperglycemia, prompting an increased adoption of continuous glucose monitoring (CGM) systems. CGM systems offer greater convenience compared to traditional fingerstick blood glucose monitoring methods. Moreover, CGM systems provide greater precision and dependability, offering individuals a precise depiction of their blood glucose levels. For example, in April 2023, Abbott Laborator ies, American multinational medical devices, and health care company, revealed that the U.S. Food and Drug Administration (FDA) had approved a reader for its FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system. This system incorporates the world's most compact, slim, and inconspicuous glucose sensor. CGM systems have a higher stake in the growth of the global glucose monitoring system market.

Increasing Demand for Sensor-based Glucose Monitoring System

Sensor technology has seen remarkable progress in recent years, resulting in the scaling of the global glucose monitoring system market. The sensors within glucose monitoring systems offer improved accuracy and reliability, while also providing increased user convenience. A minute sensor can be inserted beneath the skin, commonly in the abdominal or arm area, and secured with an adhesive patch. These sensors are referred to as disposable sensors. Alternatively, another kind of CGM sensor, an implantable sensor, can be positioned inside your body. In April 2023, Medtronic, a renowned global leader in medical technology, disclosed that the U.S. Food and Drug Administration (FDA) had approved its MiniMed 780G system, featuring the Guardia 4 sensor, eliminating the need for fingersticks when utilizing SmartGua rd technology. The sensor is designed for one-time use and necessitates a prescription. The Guardian 4 sensor is approved for continuous use for seven days.

Impact of COVID-19

The global glucose monitoring system market experienced a notable surge during the COVID-19 pandemic and is poised for robust growth, remaining resilient in the face of significant disruptions caused by the pandemic. One technology that has proven invaluable during the pandemic is real-time continuous glucose monitoring (rtCGM). RtCGM aids individuals with diabetes in enhancing and controlling their glycemic levels, effectively reducing both hyperglycemia and hypoglycemia. In three areas rtCGM emerged as a potent tool for diabetes management during the COVID-19 pandemic. Firstly, rtCGM assisted individuals within the community in managing their diabete s while under lockdown. Secondly, rtCGM was used in telehealth to enable clinics to monitor their patients remotely. Lastly, rtCGM was employed within hospitals to track patient glucose levels and minimize healthcare provider exposure to COVID-19. Therefore, the pandemic positively impacted the global glucose monitoring system market.

Key Players Landscape and Outlook

Within the dynamic of global glucose monitoring system market, mergers and collaborations play a crucial role. Corporations are actively establishing alliances to boost their product portfolios, extend their market presence, and drive innovation. This collective effort is directed toward delivering advanced solutions for diabetes management in the continuously evolving healthcare environment. In February 2023, Ascensia Diabetes Care, a leading worldwide company in diabetes care known for producing the CONTOUR Blood Glucose Monitoring (BGM) system portfolio and serving as the exclusive distributor of Eversense Continuous Glucose Monitoring (CGM) Systems, unve iled a significant international partnership with SNAQ, a highly acclaimed app-based solution that provides essential information on food and nutrition tailored for individuals with diabetes. Through their collaborative efforts to merge their technologies, Ascensia and SNAQ aim to empower a larger number of people with diabetes (PWDs) to make informed decisions about their meals, ultimately striving to enhance diabetes management.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19

4. Executive Summary

5. Global Glucose Monitoring System Market Outlook, 2017-2031F

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. By Type
    • 5.2.1. Self-Monitoring Blood Glucose (SMBG) Systems
    • 5.2.2. Continuous Glucose Monitoring (CGM) Systems
      • 5.2.1.1. Real-time CGM
      • 5.2.1.2. Intermittently Scanned CGM
  • 5.3. By Component
    • 5.3.1. Glucometer devices
    • 5.3.2. Test Strips
    • 5.3.3. Lancets
    • 5.3.4. Sensors
    • 5.3.5. Durables
  • 5.4. By Product
    • 5.4.1. Devices
    • 5.4.2. Services
  • 5.5. By Patient Care Setting
    • 5.5.1. Hospital
    • 5.5.2. Homecare
  • 5.6. By Application
    • 5.6.1. Type 1 Diabetes
    • 5.6.2. Type 2 Diabetes
    • 5.6.3. Gestational Diabetes
  • 5.7. By Modality
    • 5.7.1. Wearable
    • 5.7.2. Non-wearable
  • 5.8. By Invasiveness
    • 5.8.1. Invasive methods
    • 5.8.2. Minimally Invasive methods
    • 5.8.3. Non-invasive methods
  • 5.9. By Distribution Channel
    • 5.9.1. Retail Stores
    • 5.9.2. E-commerce
    • 5.9.3. Pharmacy
  • 5.10. By Region
    • 5.10.1. North America
    • 5.10.2. Europe
    • 5.10.3. South America
    • 5.10.4. Asia-Pacific
    • 5.10.5. Middle East and Africa
  • 5.11. By Company Market Share (%), 2023

6. Global Glucose Monitoring System Market Outlook, By Region, 2017-2031F

  • 6.1. North America*
    • 6.1.1. Market Size & Forecast
      • 6.1.1.1. Value
      • 6.1.1.2. Volume
    • 6.1.2. By Type
      • 6.1.2.1. Self-Monitoring Blood Glucose (SMBG) Systems
      • 6.1.2.2. Continuous Glucose Monitoring (CGM) Systems
      • 6.1.2.2.1. Real-time CGM
      • 6.1.2.2.2. Intermittently Scanned CGM
    • 6.1.3. By Component
      • 6.1.3.1. Glucometer devices
      • 6.1.3.2. Test Strips
      • 6.1.3.3. Lancets
      • 6.1.3.4. Sensors
      • 6.1.3.5. Durables
    • 6.1.4. By Product
      • 6.1.4.1. Devices
      • 6.1.4.2. Services
    • 6.1.5. By Patient Care Setting
      • 6.1.5.1. Hospital
      • 6.1.5.2. Homecare
    • 6.1.6. By Application
      • 6.1.6.1. Type 1 Diabetes
      • 6.1.6.2. Type 2 Diabetes
      • 6.1.6.3. Gestational Diabetes
    • 6.1.7. By Modality
      • 6.1.7.1. Wearable
      • 6.1.7.2. Non-wearable
    • 6.1.8. By Invasiveness
      • 6.1.8.1. Invasive methods
      • 6.1.8.2. Minimally Invasive methods
      • 6.1.8.3. Non-invasive methods
    • 6.1.9. By Distribution Channel
      • 6.1.9.1. Retail stores
      • 6.1.9.2. E-commerce
      • 6.1.9.3. Pharmacy
    • 6.1.10. United States*
      • 6.1.10.1. Market Size & Forecast
      • 6.1.10.1.1. Value
      • 6.1.10.1.2. Volume
      • 6.1.10.2. By Type
      • 6.1.10.2.1. Self-Monitoring Blood Glucose (SMBG) Systems
      • 6.1.10.2.2. Continuous Glucose Monitoring (CGM) Systems
      • 6.1.10.2.2.1. Real-time CGM
      • 6.1.10.2.2.2. Intermittently Scanned CGM
      • 6.1.10.3. By Component
      • 6.1.10.3.1. Glucometer devices
      • 6.1.10.3.2. Test Strips
      • 6.1.10.3.3. Lancets
      • 6.1.10.3.4. Sensors
      • 6.1.10.3.5. Durables
      • 6.1.10.4. By Product
      • 6.1.10.4.1. Devices
      • 6.1.10.4.2. Services
      • 6.1.10.5. By Patient Care Setting
      • 6.1.10.5.1. Hospital
      • 6.1.10.5.2. Homecare
      • 6.1.10.6. By Application
      • 6.1.10.6.1. Type 1 Diabetes
      • 6.1.10.6.2. Type 2 Diabetes
      • 6.1.10.6.3. Gestational Diabetes
      • 6.1.10.7. By Modality
      • 6.1.10.7.1. Wearable
      • 6.1.10.7.2. Non-wearable
      • 6.1.10.8. By Invasiveness
      • 6.1.10.8.1. Invasive methods
      • 6.1.10.8.2. Minimally invasive methods
      • 6.1.10.8.3. Non-invasive methods
      • 6.1.10.9. By Distribution Channel
      • 6.1.10.9.1. Retail Stores
      • 6.1.10.9.2. E-commerce
      • 6.1.10.9.3. Pharmacy
    • 6.1.11. Canada
    • 6.1.12. Mexico

All segments will be provided for all regions and countries covered

  • 6.2. Europe
    • 6.2.1 Germany
    • 6.2.2 France
    • 6.2.3 Italy
    • 6.2.4 United Kingdom
    • 6.2.5 Russia
    • 6.2.6 Netherlands
    • 6.2.7 Spain
    • 6.2.8 Turkey
    • 6.2.9 Poland
  • 6.3. South America
    • 6.3.1. Brazil
    • 6.3.2. Argentina
  • 6.4. Asia-Pacific
    • 6.4.1. India
    • 6.4.2. China
    • 6.4.3. Japan
    • 6.4.4. Australia
    • 6.4.5. Vietnam
    • 6.4.6. South Korea
    • 6.4.7. Indonesia
    • 6.4.8. Philippines
  • 6.5. Middle East & Africa
    • 6.5.1. Saudi Arabia
    • 6.5.2. UAE
    • 6.5.3. South Africa

7. Market Mapping, 2023

  • 7.1. By Type
  • 7.2. By Component
  • 7.3. By Product
  • 7.4. By Patient Care Setting
  • 7.5. By Application
  • 7.6. By Modality
  • 7.7. By Invasiveness
  • 7.8. By Distribution Channel
  • 7.9. By Region

8. Macro Environment and Industry Structure

  • 8.1. Supply Demand Analysis
  • 8.2. Import Export Analysis
  • 8.3. Value Chain Analysis
  • 8.4. PESTEL Analysis
    • 8.4.1. Political Factors
    • 8.4.2. Economic System
    • 8.4.3. Social Implications
    • 8.4.4. Technological Advancements
    • 8.4.5. Environmental Impacts
    • 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 8.5. Porter's Five Forces Analysis
    • 8.5.1. Supplier Power
    • 8.5.2. Buyer Power
    • 8.5.3. Substitution Threat
    • 8.5.4. Threat from New Entrant
    • 8.5.5. Competitive Rivalry

9. Market Dynamics

  • 9.1. Growth Drivers
  • 9.2. Growth Inhibitors (Challenges and Restraints)

10. Regulatory Framework and Innovation

  • 10.1 Clinical Trials
  • 10.2 Patent Landscape
  • 10.3 Regulatory Approvals
  • 10.4 Innovations/Emerging Technologies

11. Key Players Landscape

  • 11.1. Competition Matrix of Top Five Market Leaders
  • 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4. SWOT Analysis (For Five Market Players)
  • 11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

  • 14.1. Hoffmann-La Roche Ltd.
    • 14.1.1. Company Details
    • 14.1.2. Key Management Personnel
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As reported)
    • 14.1.5. Key Market Focus & Geographical Presence
    • 14.1.6. Recent Developments
  • 14.2. Abbott Laboratories
  • 14.3. LifeScan IP Holdings
  • 14.4. Ascensia Diabetes Care Holdings AG.
  • 14.5. Medtronic Plc.
  • 14.6. Dexcom, Inc.
  • 14.7. Ypsomed AG
  • 14.8. B. Braun Medical Ltd.
  • 14.9. Nipro Corporation
  • 14.10. Sanofi S.A.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15. Strategic Recommendations

16. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 4. Global Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 5. Global Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 6. Global Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 7. Global Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 8. Global Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 9. Global Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 10. Global Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 11. Global Glucose Monitoring Market Share (%), By Region, 2017-2031F
  • Figure 12. North America Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 13. North America Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 14. North America Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 15. North America Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 16. North America Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 17. North America Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 18. North America Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 19. North America Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 20. North America Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 21. North America Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 22. North America Glucose Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 23. United States Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 24. United States Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 25. United States Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 26. United States Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 27. United States Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 28. United States Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 29. United States Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 30. United States Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 31. United States Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 32. United States Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 33. Canada Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Canada Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Canada Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 36. Canada Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 37. Canada Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 38. Canada Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 39. Canada Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 40. Canada Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 41. Canada Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 42. Canada Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 43. Mexico Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 44. Mexico Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 45. Mexico Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 46. Mexico Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 47. Mexico Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 48. Mexico Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 49. Mexico Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 50. Mexico Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 51. Mexico Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 52. Mexico Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 53. Europe Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 54. Europe Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 55. Europe Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 56. Europe Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 57. Europe Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 58. Europe Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 59. Europe Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 60. Europe Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 61. Europe Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 62. Europe Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 63. Europe Glucose Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 64. Germany Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Germany Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Germany Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 67. Germany Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 68. Germany Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 69. Germany Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 70. Germany Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 71. Germany Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 72. Germany Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 73. Germany Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 74. France Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. France Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 76. France Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 77. France Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 78. France Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 79. France Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 80. France Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 81. France Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 82. France Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 83. France Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 84. Italy Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 85. Italy Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 86. Italy Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 87. Italy Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 88. Italy Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 89. Italy Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 90. Italy Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 91. Italy Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 92. Italy Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 93. Italy Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 94. United Kingdom Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. United Kingdom Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. United Kingdom Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 97. United Kingdom Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 98. United Kingdom Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 99. United Kingdom Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 100. United Kingdom Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 101. United Kingdom Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 102. United Kingdom Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 103. United Kingdom Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 104. Russia Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 105. Russia Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 106. Russia Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 107. Russia Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 108. Russia Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 109. Russia Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 110. Russia Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 111. Russia Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 112. Russia Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 113. Russia Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 114. Netherlands Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 115. Netherlands Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 116. Netherlands Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 117. Netherlands Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 118. Netherlands Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 119. Netherlands Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 120. Netherlands Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 121. Netherlands Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 122. Netherlands Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 123. Netherlands Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 124. Spain Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 125. Spain Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 126. Spain Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 127. Spain Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 128. Spain Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 129. Spain Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 130. Spain Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 131. Spain Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 132. Spain Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 133. Spain Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 134. Turkey Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 135. Turkey Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 136. Turkey Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 137. Turkey Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 138. Turkey Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 139. Turkey Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 140. Turkey Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 141. Turkey Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 142. Turkey Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 143. Turkey Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 144. Poland Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Poland Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Poland Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 147. Poland Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 148. Poland Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 149. Poland Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 150. Poland Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 151. Poland Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 152. Poland Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 153. Poland Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 154. South America Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 155. South America Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 156. South America Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 157. South America Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 158. South America Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 159. South America Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 160. South America Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 161. South America Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 162. South America Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 163. South America Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 164. South America Glucose Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 165. Brazil Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 166. Brazil Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 167. Brazil Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 168. Brazil Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 169. Brazil Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 170. Brazil Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 171. Brazil Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 172. Brazil Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 173. Brazil Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 174. Brazil Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 175. Argentina Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Argentina Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Argentina Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 178. Argentina Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 179. Argentina Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 180. Argentina Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 181. Argentina Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 182. Argentina Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 183. Argentina Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 184. Argentina Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 185. Asia-Pacific Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 186. Asia-Pacific Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 187. Asia-Pacific Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 188. Asia-Pacific Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 189. Asia-Pacific Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 190. Asia-Pacific Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 191. Asia-Pacific Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 192. Asia-Pacific Glucose Monitoring Market Share (%), By Modality, 2016-2030
  • Figure 193. Asia-Pacific Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 194. Asia-Pacific Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 195. Asia-Pacific Glucose Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 196. India Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 197. India Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 198. India Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 199. India Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 200. India Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 201. India Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 202. India Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 203. India Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 204. India Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 205. India Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 206. China Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 207. China Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 208. China Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 209. China Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 210. China Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 211. China Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 212. China Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 213. China Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 214. China Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 215. China Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 216. Japan Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 217. Japan Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 218. Japan Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 219. Japan Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 220. Japan Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 221. Japan Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 222. Japan Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 223. Japan Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 224. Japan Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 225. Japan Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 226. Australia Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 227. Australia Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 228. Australia Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 229. Australia Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 230. Australia Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 231. Australia Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 232. Australia Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 233. Australia Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 234. Australia Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 235. Australia Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 236. Vietnam Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 237. Vietnam Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 238. Vietnam Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 239. Vietnam Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 240. Vietnam Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 241. Vietnam Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 242. Vietnam Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 243. Vietnam Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 244. Vietnam Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 245. Vietnam Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 246. South Korea Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 247. South Korea Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 248. South Korea Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 249. South Korea Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 250. South Korea Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 251. South Korea Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 252. South Korea Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 253. South Korea Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 254. South Korea Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 255. South Korea Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 256. Indonesia Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 257. Indonesia Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 258. Indonesia Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 259. Indonesia Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 260. Indonesia Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 261. Indonesia Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 262. Indonesia Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 263. Indonesia Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 264. Indonesia Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 265. Indonesia Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 266. Philippines Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 267. Philippines Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 268. Philippines Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 269. Philippines Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 270. Philippines Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 271. Philippines Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 272. Philippines Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 273. Philippines Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 274. Philippines Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 275. Philippines Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 276. Middle East & Africa Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 277. Middle East & Africa Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 278. Middle East & Africa Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 279. Middle East & Africa Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 280. Middle East & Africa Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 281. Middle East & Africa Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 282. Middle East & Africa Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 283. Middle East & Africa Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 284. Middle East & Africa Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 285. Middle East & Africa Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 286. Middle East & Africa Glucose Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 287. Saudi Arabia Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 288. Saudi Arabia Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 289. Saudi Arabia Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 290. Saudi Arabia Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 291. Saudi Arabia Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 292. Saudi Arabia Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 293. Saudi Arabia Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 294. Saudi Arabia Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 295. Saudi Arabia Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 296. Saudi Arabia Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 297. UAE Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 298. UAE Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 299. UAE Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 300. UAE Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 301. UAE Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 302. UAE Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 303. UAE Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 304. UAE Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 305. UAE Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 306. UAE Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 307. South Africa Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 308. South Africa Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 309. South Africa Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 310. South Africa Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 311. South Africa Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 312. South Africa Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 313. South Africa Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 314. South Africa Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 315. South Africa Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 316. South Africa Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 317. By Types Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 318. By Component Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 319. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 320. By Patient Care Setting Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 321. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 322. By Modality Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 323. By Invasiveness Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 324. By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 325. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023